![]() |
|
|
Forward to a colleague |
||
Access Full Stories Pharmaceutical Products Development (PPD) has announced it is moving into Russia, along with the news of positive trial results for its statin, although profits dipped again during the fourth quarter of 2007 as... Read Major bio expansion for Cook Cook Pharmica has announced an $80m expansion to its biopharmaceutical facility in Bloomington, Indiana... Read AMRI builds upon Indian operations New York-based AMRI has added to its Indian operations, following the acquisition of another manufacturing plant in the country... Read Pharmaceutical outsourcing: people on the move SRI International, BASF, Richman Chemical, PDI and Codexis have all had people on the move in the world of pharmaceutical outsourcing... Read Contract manufacturing facility updates Several contract manufacturers have recently made announcements regarding updates to their facilities... Read |
||||||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||||||
![]() Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here | ||||||||||||||||||
|
Related Industry News Alpharma pockets $395m for API biz Alpharma has signed a definitive agreement with private equity group 3i for the sale of its active pharmaceutical ingredient (API) business, pocketing $395m in the deal to reinvest in its pharmaceutical and animal... Read Synthesis stumbling blocks in pharma licensing With increasing pressures on pharma pipelines leading to greater interest in compound licensing, firms can be caught out by failing to give scalability issues due attention, according to Joseph D'Antuono speaking... Read Public backs human tissue research Despite adverse publicity in the past, the UK public is becoming increasingly supportive of using human tissues in medical research, according to a new study... Read GE strengthens healthcare with $718m Whatman buy GE Healthcare has agreed to purchase UK laboratory equipment maker Whatman for £363m ($718m) in a move aimed at advancing GE's life sciences business... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||